Inositol hexakisphosphate and β-cell stimulus-secretion coupling

Christopher J. Barker, Per Olof Berggren

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Inositol hexakisphosphate (InsP6) inhibits serine/threonine protein phosphatases type-1 (PP1), type-2A (PP2A) and type-3 (PP3) in a concentration-dependent manner. Since the activity of voltage-gated L-type Ca2+-channels is increased by inhibition of serine/threonine protein phosphatases, this may explain trhe increased Ca2+-channel activity obtained in the presence of InsP6. In insulin-secreting cells, InsP6 is therefore likely to be one of the key elements modulating Ca2+-influx over the plasma membrane. InsP6 can also modulate insulin exocytosis in permeabilized cells. Concentrations of InsP6 above 20 μM stimulated insulin secretion at basal Ca2+-concentration (30 nM) and primed Ca2+-induced exocytosis (10 μM), both effects being due to activation of PKC. Hence, InsP6 can play an important modulatory role in the regulation of insulin exocytosis and the specific role may then be to recruit secretory granules to the site of exocytosis. The fact that some InsP6 is localised to membranes, so being topographically disposed to regulate ion channels as well as exocytosis, and that it has a rapid rate of turnover in glucose-stimulated insulin-secreting cells, suggest novel functions for InsP6 in the insulin secretory process.

Original languageEnglish
Pages (from-to)3737-3741
Number of pages5
JournalAnticancer Research
Volume19
Issue number5 A
StatePublished - Dec 23 1999
Externally publishedYes

Fingerprint

Phytic Acid
Exocytosis
Insulin
Insulin-Secreting Cells
Protein Phosphatase 2
Secretory Pathway
Phosphoprotein Phosphatases
Secretory Vesicles
Threonine
Ion Channels
Serine
Cell Membrane
Glucose
Membranes

Keywords

  • β-cells
  • Ca metabolism
  • Inositol hexakisphosphate
  • Insulin secretion
  • L-type Ca channel
  • Review
  • Stimulus secretion coupling

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Barker, C. J., & Berggren, P. O. (1999). Inositol hexakisphosphate and β-cell stimulus-secretion coupling. Anticancer Research, 19(5 A), 3737-3741.

Inositol hexakisphosphate and β-cell stimulus-secretion coupling. / Barker, Christopher J.; Berggren, Per Olof.

In: Anticancer Research, Vol. 19, No. 5 A, 23.12.1999, p. 3737-3741.

Research output: Contribution to journalArticle

Barker, CJ & Berggren, PO 1999, 'Inositol hexakisphosphate and β-cell stimulus-secretion coupling', Anticancer Research, vol. 19, no. 5 A, pp. 3737-3741.
Barker CJ, Berggren PO. Inositol hexakisphosphate and β-cell stimulus-secretion coupling. Anticancer Research. 1999 Dec 23;19(5 A):3737-3741.
Barker, Christopher J. ; Berggren, Per Olof. / Inositol hexakisphosphate and β-cell stimulus-secretion coupling. In: Anticancer Research. 1999 ; Vol. 19, No. 5 A. pp. 3737-3741.
@article{62c753572e784fa28c4b769f99b4fcdd,
title = "Inositol hexakisphosphate and β-cell stimulus-secretion coupling",
abstract = "Inositol hexakisphosphate (InsP6) inhibits serine/threonine protein phosphatases type-1 (PP1), type-2A (PP2A) and type-3 (PP3) in a concentration-dependent manner. Since the activity of voltage-gated L-type Ca2+-channels is increased by inhibition of serine/threonine protein phosphatases, this may explain trhe increased Ca2+-channel activity obtained in the presence of InsP6. In insulin-secreting cells, InsP6 is therefore likely to be one of the key elements modulating Ca2+-influx over the plasma membrane. InsP6 can also modulate insulin exocytosis in permeabilized cells. Concentrations of InsP6 above 20 μM stimulated insulin secretion at basal Ca2+-concentration (30 nM) and primed Ca2+-induced exocytosis (10 μM), both effects being due to activation of PKC. Hence, InsP6 can play an important modulatory role in the regulation of insulin exocytosis and the specific role may then be to recruit secretory granules to the site of exocytosis. The fact that some InsP6 is localised to membranes, so being topographically disposed to regulate ion channels as well as exocytosis, and that it has a rapid rate of turnover in glucose-stimulated insulin-secreting cells, suggest novel functions for InsP6 in the insulin secretory process.",
keywords = "β-cells, Ca metabolism, Inositol hexakisphosphate, Insulin secretion, L-type Ca channel, Review, Stimulus secretion coupling",
author = "Barker, {Christopher J.} and Berggren, {Per Olof}",
year = "1999",
month = "12",
day = "23",
language = "English",
volume = "19",
pages = "3737--3741",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5 A",

}

TY - JOUR

T1 - Inositol hexakisphosphate and β-cell stimulus-secretion coupling

AU - Barker, Christopher J.

AU - Berggren, Per Olof

PY - 1999/12/23

Y1 - 1999/12/23

N2 - Inositol hexakisphosphate (InsP6) inhibits serine/threonine protein phosphatases type-1 (PP1), type-2A (PP2A) and type-3 (PP3) in a concentration-dependent manner. Since the activity of voltage-gated L-type Ca2+-channels is increased by inhibition of serine/threonine protein phosphatases, this may explain trhe increased Ca2+-channel activity obtained in the presence of InsP6. In insulin-secreting cells, InsP6 is therefore likely to be one of the key elements modulating Ca2+-influx over the plasma membrane. InsP6 can also modulate insulin exocytosis in permeabilized cells. Concentrations of InsP6 above 20 μM stimulated insulin secretion at basal Ca2+-concentration (30 nM) and primed Ca2+-induced exocytosis (10 μM), both effects being due to activation of PKC. Hence, InsP6 can play an important modulatory role in the regulation of insulin exocytosis and the specific role may then be to recruit secretory granules to the site of exocytosis. The fact that some InsP6 is localised to membranes, so being topographically disposed to regulate ion channels as well as exocytosis, and that it has a rapid rate of turnover in glucose-stimulated insulin-secreting cells, suggest novel functions for InsP6 in the insulin secretory process.

AB - Inositol hexakisphosphate (InsP6) inhibits serine/threonine protein phosphatases type-1 (PP1), type-2A (PP2A) and type-3 (PP3) in a concentration-dependent manner. Since the activity of voltage-gated L-type Ca2+-channels is increased by inhibition of serine/threonine protein phosphatases, this may explain trhe increased Ca2+-channel activity obtained in the presence of InsP6. In insulin-secreting cells, InsP6 is therefore likely to be one of the key elements modulating Ca2+-influx over the plasma membrane. InsP6 can also modulate insulin exocytosis in permeabilized cells. Concentrations of InsP6 above 20 μM stimulated insulin secretion at basal Ca2+-concentration (30 nM) and primed Ca2+-induced exocytosis (10 μM), both effects being due to activation of PKC. Hence, InsP6 can play an important modulatory role in the regulation of insulin exocytosis and the specific role may then be to recruit secretory granules to the site of exocytosis. The fact that some InsP6 is localised to membranes, so being topographically disposed to regulate ion channels as well as exocytosis, and that it has a rapid rate of turnover in glucose-stimulated insulin-secreting cells, suggest novel functions for InsP6 in the insulin secretory process.

KW - β-cells

KW - Ca metabolism

KW - Inositol hexakisphosphate

KW - Insulin secretion

KW - L-type Ca channel

KW - Review

KW - Stimulus secretion coupling

UR - http://www.scopus.com/inward/record.url?scp=0032794435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032794435&partnerID=8YFLogxK

M3 - Article

C2 - 10625950

AN - SCOPUS:0032794435

VL - 19

SP - 3737

EP - 3741

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5 A

ER -